Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
metaLead Therapeutics Logo
metaLead Therapeutics Growth Score
77
CB Rank
96903
Heat Score
49
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Founded
obfuscation
PrivateSeed Zürich, Zurich, Switzerland1-10 metalead.ch
Biopharma
Biotechnology
Therapeutics
Overview

metaLead Therapeutics
Total Funding
obfuscation
Growth Score
77
Heat Score
49

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score77
-9 pts
in past quarter
Heat Score 49
-23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About metaLead Therapeutics

CB Rank
96903
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Founded
obfuscation
PrivateSeed Zürich, Zurich, Switzerland1-10 metalead.ch
Biopharma
Biotechnology
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Convertible Note
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name metaLead Therapeutics AG.
Operating Status Active
Company Type For Profit
About the Company
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Peptide-based Chelation Therapy for Lead Poisoning
A peptide treatment designed to selectively capture and remove toxic lead ions from the body, administered orally at low doses.
Peptide-based Treatment for Wilson Disease
A peptide therapy aimed at managing copper accumulation in patients with Wilson disease by selectively targeting copper ions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed
obfuscation
Seed Round - metaLead Therapeutics Logo
Seed Round - metaLead Therapeutics
1
obfuscation
UZH Life Sciences FundSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Board Members and Advisors 1 Contacts 2

Board Members and Advisors

News

News and Press

News•Oct 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 4, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

437
89.18%
 in past month

IT Spend

$37.1KThis year, metaLead Therapeutics is projected to spend $37.1K on IT, according to Aberdeen.

Active Website Tech Count

2metaLead Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is metaLead Therapeutics's headquarters? metaLead Therapeutics is located in Zürich, Zurich, Switzerland.Who invested in metaLead Therapeutics? metaLead Therapeutics has 3 investors including UZH Life Sciences Fund and  BioInnovation Institute.When was the last funding round for metaLead Therapeutics? metaLead Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are metaLead Therapeutics's competitors? Alternatives and possible competitors to metaLead Therapeutics may include National Institutes of Health and  Drugs.com.How much funding has metaLead Therapeutics raised to date? metaLead Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|